: Chronic lymphocytic leukemia (CLL) is characterized by a remarkably complex landscape. We performed a molecular characterization of liquid biopsies from 137 leukemia samples and 10 healthy subjects. Almost all patients express single-nucleotide polymorphism (SNP) mutations of the TP53 gene and the most common (n = 132 patients) was the Pro72Arg missense mutation. It was associated with significantly higher overall survival (p < 0.001) in untreated patients (n = 73) compared to treated patients (n = 58). However, this TP53 mutation is identified in both patients and healthy volunteers being likely a germinal mutation classified as SNP. In addition, a rare missense SNP mutation (Arg337Cys) of TP53 gene, correlated positively with clinical outcome (204 months; p = 0.00001) was also found. Its effects on p53 stability and function were subsequently evaluated. A missense mutation (Met541Leu) in the KIT gene was found in 18 patients and it was also significantly associated (p < 0.05) with a favorable outcome in untreated patients (n = 10) compared to treated ones (n = 8). We performed a comparative analysis among CLL patients classified into three prognostic groups (Binet A, B, and C). Survival analysis confirmed that Binet C patients had a significantly reduced survival compared to Binet A patients (p < 0.05).
Complex genetic landscape in CLL: Clinical impact on patients’ survival and insights into the altered molecular pathways
Giudice A.;Volpe S.;Sperlongano R.;Facchiano A.;Cossu A. M.;Bocchetti M.;Misso G.;Caraglia M.;
2025
Abstract
: Chronic lymphocytic leukemia (CLL) is characterized by a remarkably complex landscape. We performed a molecular characterization of liquid biopsies from 137 leukemia samples and 10 healthy subjects. Almost all patients express single-nucleotide polymorphism (SNP) mutations of the TP53 gene and the most common (n = 132 patients) was the Pro72Arg missense mutation. It was associated with significantly higher overall survival (p < 0.001) in untreated patients (n = 73) compared to treated patients (n = 58). However, this TP53 mutation is identified in both patients and healthy volunteers being likely a germinal mutation classified as SNP. In addition, a rare missense SNP mutation (Arg337Cys) of TP53 gene, correlated positively with clinical outcome (204 months; p = 0.00001) was also found. Its effects on p53 stability and function were subsequently evaluated. A missense mutation (Met541Leu) in the KIT gene was found in 18 patients and it was also significantly associated (p < 0.05) with a favorable outcome in untreated patients (n = 10) compared to treated ones (n = 8). We performed a comparative analysis among CLL patients classified into three prognostic groups (Binet A, B, and C). Survival analysis confirmed that Binet C patients had a significantly reduced survival compared to Binet A patients (p < 0.05).I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
